Penumbra (PEN) Cost of Revenue (2014 - 2026)
Penumbra's (PEN) quarterly Cost of Revenue came in at $121.3 million in Q1 2026, up 12.09% year-on-year from $108.3 million in Q1 2025, and down 1.55% on a QoQ basis from $123.3 million in Q4 2025.
Penumbra (PEN) Cost of Revenue (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Cost of Revenue data on file, last reported at $121.3 million in Q1 2026.
- On a quarterly basis, Cost of Revenue rose 12.09% year-over-year to $121.3 million in Q1 2026; TTM through Mar 2026 was $474.3 million, a 5.32% increase from a year earlier, with the FY2025 full-year figure at $461.2 million, up 4.92% from the prior year.
- Cost of Revenue for Q1 2026 stood at $121.3 million, down from $123.3 million in the prior quarter.
- Over the last five years, Cost of Revenue for PEN reached as high as $136.6 million in Q2 2024 and fell as low as $74.3 million in Q2 2022.
- Historically, Cost of Revenue has averaged $100.6 million across 5 years, with a median of $97.7 million in 2023.
- Across the five-year window, Cost of Revenue surged 44.31% in 2024 and declined 15.47% in 2025, its largest moves.
- Year by year, Cost of Revenue stood at $82.8 million in 2022, then increased by 18.0% to $97.7 million in 2023, then increased by 7.28% to $104.8 million in 2024, then gained by 17.62% to $123.3 million in 2025, then retreated by 1.55% to $121.3 million in 2026.
- Per Business Quant data, the three most recent Cost of Revenue figures were $121.3 million in Q1 2026, $123.3 million in Q4 2025, and $114.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | Penumbra | 12.55 Bn | 11.94 Bn | 253.41 Mn | 121.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121.35 Mn |
| Mar 31, 2026 | 121.35 Mn |
| Dec 31, 2025 | 123.26 Mn |
| Dec 31, 2025 | 123.26 Mn |
| Sep 30, 2025 | 114.27 Mn |
| Sep 30, 2025 | 114.27 Mn |
| Jun 30, 2025 | 115.45 Mn |
| Jun 30, 2025 | 115.45 Mn |
| Mar 31, 2025 | 108.26 Mn |
| Mar 31, 2025 | 108.26 Mn |
| Dec 31, 2024 | 104.80 Mn |
| Dec 31, 2024 | 104.80 Mn |
| Sep 30, 2024 | 100.73 Mn |
| Sep 30, 2024 | 100.73 Mn |
| Jun 30, 2024 | 136.57 Mn |
| Jun 30, 2024 | 136.57 Mn |
| Mar 31, 2024 | 97.52 Mn |
| Mar 31, 2024 | 97.52 Mn |
| Dec 31, 2023 | 97.69 Mn |
| Dec 31, 2023 | 97.69 Mn |